Breast Cancer Drug Perjeta Appears to Extend Patients’ Lives by 15 Months

September 29, 2014 5:39 AM

18 0

Breast Cancer Drug Perjeta Appears to Extend Patients’ Lives by 15 Months

Cancer research rarely provides such an astonishing result. Perjeta, a drug made by the Swiss drug company Roche is used in the treatment of metastatic breast cancer. This advanced form of cancer means that cancer cells have spread to other parts of the body. After a study spanning several years, researchers said that on average, Perjeta can extend the lives of breast cancer patients by 15 months.

Yes, Perjeta, generically known as pertuzumab, is already on the market since 2012. But this is the first study showing more precisely how effective the drug is. Perjeta inhibits HER2, an active protein in some breast cancer types. By combining Perjeta with Herceptin in breast cancers where HER2 is ...

Read more

To category page

Loading...